Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes

Immunopharmacology

Volumn 41, Issue 1, 1999, Pages 31-44

  Hunt, David W C ^a,b   Jiang, Huijun ^a   Granville, David J ^a,b   Chan, Agnes H ^a   Leong, Simon ^a   Levy, Julia G ^a,c  

^a QLT Phototherapeutics   (Canada)

^b Cardiovascular Research Laboratory   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Apoptosis; Interleukin 2 receptor; Lymphocyte activation; Photodynamic therapy; Photosensitizers; T lymphocytes

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; DNA FRAGMENT; FAS ANTIGEN; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MONOCLONAL ANTIBODY CD3; PHOTOSENSITIZING AGENT; T LYMPHOCYTE RECEPTOR; TRANSFERRIN RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIBODIES; ANTIGENS, CD3; APOPTOSIS; CELL DIVISION; DNA; INTERPHASE; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED DBA; PHOTOSENSITIZING AGENTS; PORPHYRINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 0032927662     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(98)00051-4     Document Type: Article

References (51)

1. Agrarwal M.L., Clay M.E., Harvey E.J., Evans H.H., Antunez A.R., Oleinick N.L. Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 51:1991;5993-5996.
2. Allison B.A., Pritchard P.H., Levy J.G. Evidence for low-density lipoprotein-mediated uptake of benzoporphyrin derivative. Br. J. Cancer. 69:1994;833-839.
3. Barrett K.E., Yen A., Bigby T.D., Montisano D., Gigli I. Inhibition of human peripheral blood lymphocyte function by protoporphyrin and longwave ultraviolet light. J. Immunol. 153:1994;3286-3294.
4. Broome H.E., Dargan C.M., Bessant E.F., Krajewski S., Reed J.C. Apoptosis and Bcl-2 expression in cultured murine splenic T cells. Immunology. 84:1995;375-382.
5. Canti G., Marelli O., Ricci L., Nicolin A. Haematoporphyrin-treated murine lymphocytes: in vitro inhibition of DNA synthesis and light-mediated inactivation of cells responsible for GVHR. Photochem. Photobiol. 34:1981;589-594.
6. Carayon P., Portier M., Dussossoy D., Bord A., Petitpretre G., Canat X., Le Fur G., Casellas P. Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood. 87:1996;3170-3178.
7. Casciola-Rosen L., Nicholson D.W., Chong T., Rowan K.R., Thornberry N.A., Miller D.K., Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183:1996;1957-1964.
8. Chowdhary R.K., Ratkay L.G., Neyndorff H.C., Richter A., Obochi M., Waterfield J., Levy J.G. The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in MRL/lpr mice. Clin. Immunol. Immunopathol. 72:1994;255-263.
9. Coffman B. Surface antigen expression and immunoglobulin rearrangement during mouse pre-B cell development. Immunol. Rev. 69:1982;5-23.
10. Elmets C.A., Bowen K.D. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. Cancer Res. 46:1986;1608-1611.
11. Fleming W.H., Alpren E.J., Uchida N., Ikuta K., Spangrude G.J., Weismann I.L. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J. Cell Biol. 122:1993;897-902.
12. Girotti A.W. Photodynamic lipid peroxidation in biological systems. Photochem. Photobiol. 51:1990;497-509.
13. Gomer C.J., Rucker N., Ferrario A., Wong S. Properties and applications of photodynamic therapy. Radiat. Res. 120:1989;1-18.
14. Granville D.J., Levy J.G., Hunt D.W.C. Photodynamic therapy induces caspase-3 activation in HL-60 cells. Cell Death and Different. 4:1997;623-628.
15. Gross J.A., Callas E., Allison J.P. Identification and distribution of the costimulatory receptor CD28 in the mouse. J. Immunol. 149:1992;380-388.
16. Hannun Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood. 89:1997;1845-1853.
17. Henderson B.W., Dougherty T.J. How does photodynamic therapy work? Photochem. Photobiol. 55:1992;145-157.
18. Ho Y.K., Smith G.R., Brown M.S., Goldstein J.L. Low density lipoprotein (LDL) receptor activity in human acute myelogenous leukaemia cells. Blood. 56:1979;1099-1114.
19. Hryhorenko E., Rittenhouse-Diakun, Harvey N.S., Morgan J., Stewart C.C., Oseroff A.R. Characterization of endogenous protoporphyrin IX induced by δ-amino-levulinic acid in resting and activated peripheral blood lymphocytes by four-color flow cytometry. Photochem. Photobiol. 67:1998;565-572.
20. Hunt D.W.C., Jiang H.J., Levy J.G., Chan A.H. Sensitivity of activated murine peritoneal macrophages to photodynamic killing with benzoporphyrin derivative. Photochem. Photobiol. 61:1995;417-421.
21. Jenkins M.K., Chen C., Jung G., Mueller D.L., Shwartz R.H. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144:1990;16-22.
22. Kemp J.D. The role of iron binding proteins in lymphocyte physiology and pathology. J. Clin. Immunol. 13:1993;81-92.
23. Kemp J.D., Thorson J.A., McAlmont T.H., Horowitz M., Cowdery J.S., Ballas Z.K. Role of the transferrin receptor in lymphocyte growth: a rat IgG monoclonal antibody against the murine transferrin receptor produces highly selective inhibition of T and B cell activation protocols. J. Immunol. 138:1987;2422-2426.
24. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med. 3:1997;614-620.
25. Kubo R.T., Born W., Kappler J.W., Marrack P., Pigeon M. Characterization of a monoclonal antibody which detects all murine αβ T cell receptors. J. Immunol. 142:1989;2736-2742.
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
27. Ledbetter J.A., Herzenberg L.A. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:1979;63-90.
28. Leo O., Foo M., Sachs D.H., Samelson L.E., Bluestone J. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. U.S.A. 84:1987;1374-1378.
29. Leong S., Chan A.H., Levy J.G., Hunt D.W.C. Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimental autoimmune encephalomyelitis. Photochem. Photobiol. 64:1996;751-757.
30. Levy J.G. Photodynamic therapy. Trends Biotech. 13:1995;14-18.
31. Luo Y., Chang C.K., Kessel D. Rapid initiation of apoptosis by photodynamic therapy. Photochem. Photobiol. 63:1996;528-534.
32. Minami Y., Kono T., Miyazaki T., Taniguchi T. The IL-2 receptor complex: Its structure, function, and target genes. Annu. Rev. Immunol. 11:1993;245-267.
33. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
34. Musser D.A., Fiel R.J. Cutaneous photosensitising and immunosuppressive effects of a series of tumour localizing porphyrins. Photochem. Photobiol. 53:1991;119-123.
35. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
36. Nicoletti I., Migliorati G., Pagliacci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide and flow cytometry. J. Immunol. Methods. 139:1991;271-316.
37. North J., Neyndorff H., Levy J.G. Photosensitizers as virucidal agents. J. Photochem. Photobiol. 17:1993;99-108.
38. Obochi M.O.K., Canaan A.J., Jain A.K., Richter A.M., Levy J.G. Targeting activated lymphocytes with photodynamic therapy: susceptibility of mitogen-stimulated splenic lymphocytes to benzoporphyrin derivative (BPD) photosensitization. Photochem. Photobiol. 62:1995;169-175.
39. Ogasawara J., Watanabe-Fukunaga R., Adachi M., Matsuzama A., Kusugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effects of the anti-Fas antibody in mice. Nature. 364:1993;806-809.
40. Ortega G.O., Robb R.J., Shevach E.M., Malek T.R. The murine IL 2 receptor: I. Monoclonal antibodies that define distinct functional eptitopes on activated T cells and react with activated B cells. J. Immunol. 133:1984;1970-1975.
41. Otsuji M., Yoshimitsu K., Aoe T., Okamoto Y., Saito T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3ζ chain of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl. Acad. Sci. U.S.A. 93:1996;13119-13124.
42. Ratkay L.G., Chowdhary R.K., Neyndorff H.C., Tonzetich J., Waterfield J.D., Levy J.G. Photodynamic therapy: a comparison with other immunomodulatory treatments of adjuvant-enhanced arthritis in MRL/lpr mice. Clin. Immunol. Immunopathol. 95:1994;373-377.
43. Reed J.C. Double identity for proteins of the Bcl-2 family. Nature. 387:1997;773-776.
44. Reed J.C., Tsujimoto Y., Alpers J.D., Croce C.M., Nowell P.C. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science. 236:1987;1295-1299.
45. Robinson P.J. Phosphatidylinositol membrane anchors and T-cell activation. Immunol. Today. 12:1991;35-41.
46. Scheynius A., Camp R.L., Pure E. Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J. Immunol. 150:1993;655-663.
47. Sentman C.L., Shutter J.R., Hochenberry D., Kanagawa O., Korsmeyer S.J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67:1991;879-888.
48. Simkin G.O., King D.E., Levy J.G., Chan A.H., Hunt D.W.C. Inhibition of contact hypersensitivity with different analogs of benzoporphyrin derivative. Immunopharmacology. 37:1997;221-230.
49. Tanaka T., Tsudo M., Karasuyama H., Kitamura F., Kono T., Hatakeyama M., Taniguchi T., Miyasaka M. A novel monoclonal antibody against murine IL-2 receptor β chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells. J. Immunol. 147:1991;2222-2229.
50. Verma A., Nye J.S., Snyder S.H. Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc. Natl. Acad. Sci. U.S.A. 84:1987;2256-2260.
51. Verma A., Facchina S.L., Hirsch D.J., Song S.-Y., Dillahey L.F., Williams J.R., Snyder S.H. Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target. Mol. Med. 4:1998;40-45.